Skip to main content

Advertisement

Springer Nature Link
Log in

Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

The implication of myocardin and homeodomain only protein (HOP) in combinatorial molecular pathways that guide heart development and cardio-specific gene expression has recently been reported. However, expression of these genes in the failing heart has not yet been investigated. This study was designed to elaborate a molecular profile of myocardin and HOP expression in the failing ventricular myocardium through the use of both explanted human heart samples and heart biopsies from neonatal piglets with doxorubicin-induced cardiomyopathy (Dox-CM). Myocardin and HOP mRNA levels were estimated by both northern blot hybridization and semiquantitative RT-PCR in human ventricular preparations in end-stage failure due to dilated cardiomyopathy (DCM), as well as in nonfailing donor hearts. Similar experiments were performed with ventricular samples from normal and Dox-treated neonatal piglets. The gene expression of brain natriuretic peptide (BNP) was used as a molecular marker of myocardial damage and failure. The study revealed the following novel findings: (1) myocardin transcripts are detected in neonatal human and pig hearts at lower levels than in mature cardiac tissues, (2) the myocardin transcript pool is significantly augmented in the failing human and porcine myocardium as compared to that in nonfailing heart samples, (3) in the failing human myocardium, increased levels of myocardin mRNA are associated with a diminished HOP transcript content, and (4) the inverse proportion in cardiac myocardin/HOP mRNA pools observed in explanted human hearts is also traceable in normal human heart and aorta. A possible dual consequence of increased myocardin and decreased HOP expression levels on serum response factor-dependent cardiac-specific expression in the normal heart and at heart failure is discussed. Therefore, increased abundance of the myocardin mRNA pool is judged to be a novel CM-related feature which, alone or in association with decreased HOP transcript levels, can be responsible for dysregulation of myocardin-mediated gene expression in failing myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–D.
Fig. 2.
Fig. 3A–H.
Fig. 4A–D.
Fig. 5A–C.
Fig. 6A–C.

Similar content being viewed by others

Abbreviations

Dox-CM :

Doxorubicin-induced cardiomyopathy

RT-PCR :

Reverse transcriptase-polymerase chain reaction

BNP :

Brain natriuretic peptide

ANP :

Atrial natriuretic peptide

DCM :

Dilated cardiomyopathy

LV :

Left ventricle

RV :

Right ventricle

LA :

Left atrium

RA :

Right atrium

AP :

Apex of the heart

NIS :

Normal isotonic saline

HOP :

Homeodomain only protein

SRF :

Serum response factor

SMC :

Smooth muscle cells

UTR :

Untranslated region

FW :

Free-wall

MLC2v :

Myosin light chain 2 ventricular form

SM-A :

Smooth muscle alpha actin

Alpha-MHC :

Alpha myosin heavy chain

References

  1. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851–862

    Article  CAS  PubMed  Google Scholar 

  2. Chen J, Kitchen CM, Streb JW, Miano JM (2002) Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34:1345–1356

    Article  CAS  PubMed  Google Scholar 

  3. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS (2003) Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 23:2425–2437

    Article  CAS  PubMed  Google Scholar 

  4. Yoshida T, Sinha S, Dandre F, Wamhoff BR, Hoofnagle MH, Kremer BE, Wang DZ, Olson EN, Owens GK (2003) Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 92:856–865

    Article  CAS  PubMed  Google Scholar 

  5. Kumar MS, Owens GK (2003) Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 23:737–747

    Article  CAS  PubMed  Google Scholar 

  6. Chien KR, Olson EN (2002) Converging pathways and principles in heart development and disease: CV@CSH. Cell 110:153–162

    CAS  PubMed  Google Scholar 

  7. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, Richardson JA, Nordheim A, Olson EN (2002) Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A 99:14855–14860

    Article  CAS  PubMed  Google Scholar 

  8. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J, Misra RP, Wei JY (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280:H1782–1792

    CAS  PubMed  Google Scholar 

  9. Zhang X, Chai J, Azhar G, Sheridan P, Borras AM, Furr MC, Khrapko K, Lawitts J, Misra RP, Wei JY (2001) Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem 276:40033–40040

    Article  CAS  PubMed  Google Scholar 

  10. Chai J, Tarnawski AS (2002) Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 53:147–157

    CAS  PubMed  Google Scholar 

  11. Davis FJ, Gupta M, Pogwizd SM, Bacha E, Jeevanandam V, Gupta MP (2002) Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts. Am J Physiol Heart Circ Physiol 282:H1521–1533

    CAS  PubMed  Google Scholar 

  12. Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, Harris TM, Yamagishi H, Richardson JA, Childs G, Olson EN (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110:725–735

    CAS  PubMed  Google Scholar 

  13. Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, Runke G, Mackay JP, Novotny J, Schwartz RJ, Harvey RP, Mullins MC, Epstein JA (2002) Hop is an unusual homeobox gene that modulates cardiac development. Cell 110:713–723

    CAS  PubMed  Google Scholar 

  14. (1997) World Medical Association. World Medical Association declaration of Helsinki. Cardiovasc Res 35:2–3

    PubMed  Google Scholar 

  15. Ahmed F, Torrado M, Johnson E, Morrison J, Tomarev SI (2001) Changes in mRNA levels of the Myoc/Tigr gene in the rat eye after experimental elevation of intraocular pressure or optic nerve transection. Invest Ophthalmol Vis Sci 42:3165–3172

    CAS  PubMed  Google Scholar 

  16. Torrado M, Lopez E, Centeno A, Castro-Beiras A, Mikhailov AT (2003) The asymmetric distribution of the CARP mRNA in the left and right ventricle myocardium of the piglet heart is altered in a postnatal model of doxorubucin-induced heart failure. Eur J Heart Fail Suppl 2:10

    Google Scholar 

  17. Sussman MA, Hamm-Alvarez SF, Vilalta PM, Welch S, Kedes L (1997) Involvement of phosphorylation in doxorubicin-mediated myofibril degeneration. An immunofluorescence microscopy analysis. Circ Res 80:52–61

    CAS  PubMed  Google Scholar 

  18. Kremer LC, Tiel-van Buul MM, Ubbink MC, Offringa M, Ottenkamp J, Olmos RV, Voute PA (1999) Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children. J Clin Oncol 17:1208

    CAS  PubMed  Google Scholar 

  19. Wang Z, Wang DZ, Pipes GC, Olson EN (2003) Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 100:7129–7134

    Article  CAS  PubMed  Google Scholar 

  20. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR (1997) Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100:2315–2324

    CAS  PubMed  Google Scholar 

  21. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104:2923–2931

    CAS  PubMed  Google Scholar 

  22. Haase D, Lehmann MH, Korner MM, Korfer R, Sigusch HH, Figulla HR (2002) Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy. Eur J Heart Fail 4:23–31

    Article  CAS  PubMed  Google Scholar 

  23. Adachi S, Ito H, Tamamori M, Tanaka M, Marumo F, Hiroe M (1998) Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. Life Sci 63:1779–1791

    Article  CAS  PubMed  Google Scholar 

  24. Miyata S, Minobe W, Bristow MR, Leinwand LA (2000) Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86:386–390

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a long-time grant (SAF2001-0910) from the Spanish Ministry of Science and Technology and by infrastructure funding (2002) from the Autonomic Government of Galicia (Spain). We thank Dr. Marisa Crespo and Dr. J. Muñiz for their help in sampling and characterization of human heart tissues. We are grateful to Dr. Esperanza Cerdán for welcoming our northern blot hybridization experiments in her laboratory. We wish to thank two anonymous reviewers for constructive comments on the first version of the manuscript.

Author information

Authors and Affiliations

  1. Developmental Biology Unit, Institute of Health Sciences, University of La Coruña, Campus de Oza, Bldg. "El Fortín", As Xubias s/n, 15006, La Coruña, Spain

    Mario Torrado & Alexander T. Mikhailov

  2. University Hospital "Juan Canalejo", As Xubias arriba, 15006, La Coruña, Spain

    Eduardo López, Alberto Centeno, Constancio Medrano & Alfonso Castro-Beiras

Authors
  1. Mario Torrado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eduardo López
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Centeno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Constancio Medrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alfonso Castro-Beiras
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexander T. Mikhailov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander T. Mikhailov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torrado, M., López, E., Centeno, A. et al. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J Mol Med 81, 566–577 (2003). https://doi.org/10.1007/s00109-003-0470-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-003-0470-7

Keywords

Search

Navigation